KI
UTHR icon

Kapitalo Investimentos’s United Therapeutics UTHR Stock Holding History

Kapitalo Investimentos’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,470
Closed -$527K – 354
2024
Q3 		$527K Buy
1,470
+602
+69% +$203K 0.13% 45
2024
Q2 		$277K Buy
+868
New +$230K 0.08% 93
2024
Q1 		– Sell
-1,669
Closed -$367K – 549
2023
Q4 		$367K Sell
1,669
-1,093
-40% -$252K 0.08% 149
2023
Q3 		$624K Buy
+2,762
New +$636K 0.08% 82
2023
Q2 		– Sell
-554
Closed -$124K – 706
2023
Q1 		$124K Buy
+554
New +$137K 0.04% 276

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Kapitalo Investimentos's UTHR Position: Q4 2024 in Review

Kapitalo Investimentos sold out of United Therapeutics (UTHR) in Q4 2024, closing a stake of 1,470 shares — an estimated $527K sold.

Kapitalo Investimentos first reported a position in UTHR in Q1 2023 and held it in 5 quarters. The position peaked at $624K in Q3 2023. 673 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

  • Kapitalo Investimentos reported no remaining United Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Kapitalo Investimentos sold 1,470 United Therapeutics shares in Q4 2024, an estimated $527K.
  • Kapitalo Investimentos first reported a position in United Therapeutics in Q1 2023 and held it in 5 quarters.
  • Kapitalo Investimentos's United Therapeutics position peaked at $624K in Q3 2023.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on Kapitalo Investimentos's 13F filing for Q4 2024, filed 14 Feb 2025.